German Sepsis Society
Technical realization of the online Lectures was sponsored
by
Presentations
For the Author`s scientific profile at BIOMEDEXPERTS, please click author
Why sepsis goes public
K. Reinhart
Klinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Jena, Jena, Germany
Start Presentation
Key Note Lecture: Sepsis as main cause of death in children
N. Kissoon
Department of Pediatrics, University of British Columbia, Vancouver, Canada
Start Presentation
Hot Topics
Why we need the CHEST trial on the safety and efficacy of HES 130/04
J. Myburgh
Department of Intensive Care Medicine, The George Institute for International Health
Sydney, Australia
Start Presentation
ICU patients with A/H1N1 influenca – experiences and unsolved problems
A. Kumar
University of Manitoba, Health Sciences Centre, St. Boniface Hospital,Winnipeg, Manitoba, USA
Start Presentation
Nosocomial infections – an interdisciplinary challenge
Prevention of multiresistant bacteria – the Dutch experience
M. Bonten
Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands
Start Presentation
Prevention of sepsis
SDD versus SOD – when and how
M. Bonten
Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands
Start Presentation
Update and controversies on adjunctive therapies of sepsis
Update on corticosteroids
Ch. Sprung
Department of Anesthesiology and Critical Care Medicine, Hadassah University Hospital Ein-Karem, Jerusalem, Israel
Start Presentation
Anticoagulatory strategies – an update
S. Opal
Division of Infectious Diseases, The Memorial Hospital of Rhode Island, Pawtucket, USA
Start Presentation
Selenium
D. Heyland
Department of Medicine, Kingston General Hospital, Kingston, Canada
Start Presentation
To follow the lectures of the Lunchsymposium:
Selenium in Intensive Care from an International Point of View
sponsored by biosyn Arzneimittel GmbH, please contact Ms. Julia Staiger at biosyn
Does early administration of selenium improve neurological
outcome after cardiac arrest?
Johann Reisinger, Austria
The possible role of selenium in the peri-operative period
Zsolt Molnár, Hungary
The first experience of using selenase in patients with long-term
unconscious stage
Ruslan Nazarov, Russia
Adjunctive therapy of sepsis – new promising therapeutic targets
Immunomodulatory therapy of sepsis
R. Hotchkiss
Critical Care Division, Washington University School of Medicine, St. Louis, USA
Start Presentation
Immunglobulins in sepsis – how strong is the evidence
K. Werdan
Universitätsklinik und Poliklinik für Innere Medizin III, Klinikum der MLU Halle-Wittenberg, Halle, Germany
Start Presentation
Anti-Toll-like receptor strategies
R. R. Schumann
Institut für Mikrobiologie und Hygiene, Charité – Universitätsmedizin Berlin, Berlin, Germany
Rational use of antimicrobials in sepsis
Indications for new generation antifungals
G. Maschmeyer
Klinik für Hämatologie und Onkologie, Ernst-von-Bergmann-Klinikum, Potsdam, Germany
Start Presentation
How can we bring evidence based medicine to the bedside
Pitfalls in the applicazion of clinical trial results
Ch. Natanson
Critical Care Medicine Department, National Institutes of Health, Bethesda, USA
Start Presentation
How and why sepsis bundles reduce mortality
P. Dellinger
Section of Critical Care Medicine, Cooper University Hospital, Camden, USA
Start Presentation
Impact of sepsis bundles in Spain
A. Artigas Raventós
Medicina Intensiva, Corporació Sanitària Parc Taulí, Barcelona, Spain
Start Presentation
New insights in the pathophysiology of sepsis
Why sepsis patients die – mechanism of organ failure
R. Hotchkiss
Critical Care Division, Washington University School of Medicine, St. Louis, USA
Start Presentation
Prevention and treatment of organ dysfunction
Modulation of perfusion and oxygenation
G. Marx
Fachübergreifende Klinik für operative Intensivmedizin Erwachsene,
Universitätsklinikum Aachen, Aachen, Germany
Start Presentation
Volume replacement
A. Meier-Hellmann
Klinik für Anästhesie, Intensivmedizin und Schmerztherapie, Helios-Klinikum Erfurt GmbH, Erfurt, Germany
Start Presentation
Lung injury
G. Bernard
Office of Research, Vanderbilt University School of Medicine, Nashville, USA
Start Presentation
Respiratory therapy in ALI
L. Gattinoni
Dipartimento Terapia Intensiva, Università degli Studi di Milano, Milan, Italy
Start Presentation
Drug therapy in ALI
W. Seeger
Klinik für Innere Medizin II, Universitätsklinikum Giessen, Giessen, Germany
Start Presentation
Liver failure
M. Bauer
Klinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Jena, Jena, Germany
Start Presentation
Renal replacement therapy
S. John
Medizinische Klinik 4, Universitätsklinikum Leipzig, Erlangen, Germany
Start Presentation
Metabolic control of sepsis
Prevention and treatment of metabolic failure
G. Gutierrez
Pulmonary and Critical Care Medicine, The George Washington University Medical Center, Washington, USA
Start Presentation
Lessons from the NICE SUGAR trial
D. Heyland
Department of Medicine, Kingston General Hospital, Kingston, Canada
Start Presentation
Tight glucose control – what remains for daily clinical practice
F. M. Brunkhorst
Klinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Jena
Jena, Germany
Start Presentation
Clinical benefit of new and known sepsis markers
Risk assessment and progression markers
F. Bloos
Klinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Jena
Jena, Germany
Procalcitonin for antibiotic stewardship
B. Müller
Klinik für Allgemeine Innere Medizin, Kantonsspital Aarau, Aargau, Switzerland
Start Presentation
Transcriptomic signatures in SIRS and sepsis
M. Bauer
Klinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Jena, Germany
Start Presentation
